MedPath

Prevention of panic disorder: A randomised clinical trial adjoining cost-effectiveness study.

Completed
Conditions
In the Netherlands, each year 242.000 peope aged 18-65 years suffer from panic disorder. Panic disorder is a severe and persistent mental disorder, associated with a high degree of subjective distress, occupational and social disability. For these reasons, prevention of panic disorder is an important issue.
Registration Number
NL-OMON29238
Lead Sponsor
Trimbos Institute/Netherlands Instute of Mental Health and Addiction (G. Willemse, F. Smit)GGNet (P. Meulenbeek)Vrije Universiteit Amsterdam (P. Cuijpers)
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
286
Inclusion Criteria

Persons aged 18-65 with subclinical panic disorder (symptoms), with or without symptoms of agoraphobia.

Exclusion Criteria

1. Score of 13 or higher on the Panic Disorder Severity Scale (PDSS);

2. DSM-IV diagnosis of panic disorder;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of DSM-IV panic disorder.
Secondary Outcome Measures
NameTimeMethod
1. Panic symptoms;<br /><br>2. Quality of life;<br /><br>3. Economic costs.
© Copyright 2025. All Rights Reserved by MedPath